Melbourne, VIC, 3000, Australia
Since MPC produce the proteoglycan materials found in discs, Mesoblast envisages that the injection of MPC into a degenerated intervertebral disc will lead to replacement of the protoeglycan of cartilage. This approach, with its anticipated ease of application and lack of side-effects, should offer a relatively non-invasive and cost-effective therapy for patients with moderate or se ...
Read More...
275 Madison Ave 4th floor, New York, NY, 10016, USA
MPC therapy is the Angioblasts most advanced product, and has achieved outstanding results in extensive pre-clinical development in animal models of several cardiovascular diseases, including studies focused on the regeneration and repair of heart muscle and growth of new blood vessels following a heart attack injury. This product represents what Angioblast believes is the world's l ...
Read More...
RNL-Astrostem is administered by intravenous infusion so patients don’t have to worry about any invasive and painful surgical procedure. Dr. Jeong Chan Ra, CEO of the firm, said “Our stem cell therapeutics involves no immune rejection because the stem cells are exactly patients own. Our adult stem cell has no tumorigenicity activity at all while embryonic stem cell faces high risk o ...
Read More...
230 Constitution Drive, Menlo Park, California, 94025, USA
Geron is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes. The company is advancing an anti-cancer drug and a cancer vaccine that target the enzyme telomerase through multiple clinical trials. Geron is also the world leader in the development of human embryonic stem ce ...
Read More...
13859 Progress Blvd Suite 100, Alachua, Florida, 32615, USA
(from website) AxoGen® Inc. was founded in 2002 to focus on improving peripheral nerve repair.AxoGen has unique knowledge in processing nerve tissue which preserves the three dimensional scaffold of the tissue. AxoGen provides the first distributed peripheral nerve repair option which preserves the nerve extracellular matrix.
AlloCure begin an AKI Phase I Clinical Trial in July 2008. AlloCure is selecting patients who are at high risk for developing AKI (Acute kidney injury) after cardiac surgery. Immediately after the cardiac surgery is completed, the surgeon will administer AlloCure’s cells to the patient. The Phase I Clinical Trial has been designed to test, in a dose escalation protoco ...
Read More...
Medistem is developing technologies related to adult stem cell extraction, manipulation, and use for treating inflammatory and degenerative diseases. The Company has filed an Investigational New Drug (IND) application with the FDA for use of its universal donor endometrial regenerative cells (ERC) for treatment of critical limb ischemia, an advanced form of peripheral artery disease ...
Read More...
This site complies with the HONcode standard for trustworthy health
information:
verify here.
About - Terms of use - Privacy Policy
Upgrade Your Body (TM) is a project run by Consolidated Computing Pty Ltd.